GBS Venture Partners Ltd.
Venture capitalMelbourne · Seed–Growth · 2 people tracked
Investment thesis
GBS Venture Partners Ltd. is a life science-focused venture capital firm with $400 million under management that invests in early-stage companies across Australasia and the U.S. West Coast. The firm has backed over 30 portfolio companies since its inception.
Team · 2 people
from public directoriesWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:United States×1
Investments · 1 tracked
founders shown can be your intro pathBiotechCambridge, US
Timothy Barberich(Director)Anthony McKinney(President and Chief Executive Officer)Campbell Murray(Director)Albert L. Sokol(Secretary)Jeffrey Bailey(Director)William Pappafotopoulos(Chief Accounting and Administrative Officer)
Board seatBrigitte Smith· per SEC Form D · $500K raise · filed Jun 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does GBS Venture Partners Ltd. invest at?
- GBS Venture Partners Ltd. invests at the Seed, Series A, Series B, Series C, Growth stages.
- What is GBS Venture Partners Ltd.'s typical check size?
- GBS Venture Partners Ltd. typically writes checks of $165K – $7.9M.
- What sectors does GBS Venture Partners Ltd. focus on?
- GBS Venture Partners Ltd. focuses on Biotech, Cleantech, Healthtech, Medical Devices.
- Where is GBS Venture Partners Ltd. located?
- GBS Venture Partners Ltd. is headquartered in Melbourne, AU.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
Capricorn Venture Partners is a European investment firm managing several thematic funds across growth capital, healthcare, and cleantech, as well as a combined private/quoted investment vehicle.
OneVentures is a later-stage venture capital firm that backs technology and healthcare companies, providing growth equity and credit alongside strategic and operational support.
Odyssée Venture is a French private equity/venture capital firm specializing in growth-stage SMEs, having financed nearly 200 French growth companies over 25 years through FCPI, FIP and FCPR funds.
Portfolia operates thematic venture capital funds designed for women investors, backing companies in areas such as women's health, longevity, active aging, greentech, and fintech, while offering an educational and community-driven investing experience.